Background: The incidence of adenocarcinoma of the esophagogastric junction (AEJ) is increasing, and with poor prognosis. Lymph node status (LNs) is particularly important for planning treatment and evaluating the prognosis of patients with AEJ. However, the use of radiomic based on enhanced computed tomography (CT) to predict the preoperative lymph node metastasis (PLNM) status of the AEJ has yet to be reported.
Purpose: We sought to investigate the value of radiomic features based on enhanced CT in the accurate prediction of PLNM in patients with AEJ.
Methods: Clinical features and enhanced CT data of 235 patients with AEJ from October 2017 to May 2023 were retrospectively analyzed. The data were randomly assigned to the training cohort (n = 164) or the external testing cohort (n = 71) at a ratio of 7:3. A CT-report model, clinical model, radiomic model, and radiomic-clinical combined model were developed to predict PLNM in patients with AEJ. Univariate and multivariate logistic regression were used to screen for independent clinical risk factors. Least absolute shrinkage and selection operator (LASSO) regression was used to select the radiomic features. Finally, a nomogram for the preoperative prediction of PLNM in AEJ was constructed by combining Radiomics-score and clinical risk factors. The models were evaluated by area under the receiver operating characteristic curve (AUC-ROC), calibration curve, and decision curve analyses.
Results: A total of 181 patients (181/235, 77.02%) had LNM. In the testing cohort, the AUC of the radiomic-clinical model was 0.863 [95% confidence interval (CI) = 0.738-0.957], and the radiomic model (0.816; 95% CI = 0.681-0.929), clinical model (0.792; 95% CI = 0.677-0.888), and CT-report model (0.755; 95% CI = 0.647-0.840).
Conclusion: The radiomic-clinical model is a feasible method for predicting PLNM in patients with AEJ, helping to guide clinical decision-making and personalized treatment planning.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/mp.17374 | DOI Listing |
Aust Endod J
December 2024
Associate Professor, Department of Endodontics, Faculty of Dentistry, Cairo University, Cairo, Egypt.
This clinical study assessed the effectiveness of diode laser-980 nm as adjuvant in retreatment of failed endodontic cases with chronic periapical lesions on basis of IL-8 expression and postoperative pain when compared to placebo. For 28 patients, the pre-instrumentation periapical samples (S1) were gathered, following retreatment. After chemo-mechanical preparation, post-instrumentation samples (S2) were collected.
View Article and Find Full Text PDFCancer Cell
December 2024
Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Heart Lung Circ
November 2024
Southern Adelaide Diabetes and Endocrine Services, Southern Adelaide Local Health Network, Adelaide, SA, Australia; Department of Clinical Pharmacology, Southern Adelaide Local Health Network, Adelaide, SA, Australia; College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Aust Endod J
December 2024
School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.
This case report describes a successful autotransplantation procedure for an impacted mandibular left second premolar with incomplete root formation. Despite caries and root resorption, the patient's mandibular left second primary molar was retained. Furthermore, the severe impaction of the mandibular left second premolar ruled out orthodontic realignment.
View Article and Find Full Text PDFArthroscopy
October 2024
Department of Orthopaedics & Rehabilitation, Yale School of Medicine, New Haven, Connecticut, U.S.A.. Electronic address:
Purpose: To investigate the potential impact of preoperative semaglutide use (the active agent in Ozempic and Wegovy) on 90-day postoperative outcomes and 2-year rotator cuff retear after arthroscopic rotator cuff repair (ARCR) in patients with type II diabetes mellitus (T2DM).
Methods: Patients with T2DM undergoing primary ARCR were identified from the PearlDiver database using administrative billing codes. Exclusion criteria included patients <18 years old; previous RCR; concurrent nonrotator cuff-related arthroscopic shoulder procedures; any traumatic, neoplastic, or infectious diagnoses within 90 days before surgery; and <90-days follow-up.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!